For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Oncology Biosimilars are kind of Biosimilars. A biosimilar product is a biologic agent that is highly similar to an already-approved biological compound, known as the reference or originator product, and approved for use in the same indications as the reference product
The Oncology Biosimilars market revenue was 3391.63 Million USD in 2022, and will reach 7549.15 Million USD in 2028, with a CAGR of 14.27% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Oncology Biosimilars industry, and breaks down according to the type, application, and consumption area of Oncology Biosimilars. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Oncology Biosimilars in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Oncology Biosimilars market covered in Chapter 11:
Dr. Reddy's Laboratories
F Hoffmann-La Roche
Teva Pharmaceutical Industries Ltd.
STADA Arzneimittel AG
Intas Pharmaceuticals Ltd.
Sandoz International GmbH
In Chapter 3, on the basis of types, the Oncology Biosimilars market from 2018 to 2028 is primarily split into:
In Chapter 4, on the basis of applications, the Oncology Biosimilars market from 2018 to 2028 covers:
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
Europe (Covered in Chapter 7)
Asia-Pacific (Covered in Chapter 8)
Middle East and Africa (Covered in Chapter 9)
South America (Covered in Chapter 10)
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028